Literature DB >> 877547

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.

C E Myers, W P McGuire, R H Liss, I Ifrim, K Grotzinger, R C Young.   

Abstract

The antitumor antibiotic, adriamycin, induces severe cardiac toxicity associated with peroxidation of cardiac lipids in mice. Both this lipid peroxidation and cardiac toxicity of adriamycin are reduced by prior treatment of the animals with the free radical scavenger tocopherol. Such treatment with tocopherol does not, however, alter the magnitude or duration of the adriamycin-induced suppression of DNA synthesis in P388 ascites tumor, nor does it diminish the antitumor responsiveness of P388 ascites tumor. These results suggest that adriamycin has at least two mechanisms of tissue damage: one, which involves lipid peroxidation, is blocked by tocopherol and results in cardiac toxicity; the other, which involves binding to DNA, is not antagonized by tocopherol and is responsible for tumor response.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 877547     DOI: 10.1126/science.877547

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  190 in total

1.  Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.

Authors:  K Saito; K Takeda; S Okamoto; R Okamoto; K Makino; Y Tameda; Y Nomura; H Maeda; T Ichihara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

3.  Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

Authors:  Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Shingo Matsumoto; Keita Saito; Sándor Bátkai; Vivek Patel; Galin Tanchian; Rachel Y Gao; Benjamin F Cravatt; György Haskó; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

Review 4.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

5.  Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women.

Authors:  Y Cottin; C Touzery; B Coudert; S Richebourg; M Cohen; M Toubeau; P Louis; J E Wolf; F Brunotte
Journal:  Eur J Nucl Med       Date:  1996-05

6.  Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.

Authors:  Kelly Shum; Amber Solivan; Parham Parto; Nichole Polin; Eiman Jahangir
Journal:  Ochsner J       Date:  2016

7.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

8.  Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.

Authors:  F A Bu'Lock; H M Gabriel; A Oakhill; M G Mott; R P Martin
Journal:  Br Heart J       Date:  1993-08

9.  Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice.

Authors:  D Deprez-de Campeneere; R Baurain; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

10.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.